Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
about
Harm reduction--the cannabis paradoxFacts and fiction: the impact of hypothermia on molecular mechanisms following major challengeThe biological significance of evolution in autoimmune phenomenaBinding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissueTraumatic brain injury causes long-term reduction in serum growth hormone and persistent astrocytosis in the cortico-hypothalamo-pituitary axis of adult male rats.The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations.Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice.Acetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat model.Inflammatory cytokine-associated depressionReversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 βRole of brain inflammation in epileptogenesis.Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.Interleukin-1β enhances neuronal vulnerability to proNGF-mediated apoptosis by increasing surface expression of p75(NTR) and sortillin.Use of hypothermia in the intensive care unit.Inflammation in adult and neonatal stroke.Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.Live imaging of the innate immune response in neonates reveals differential TLR2 dependent activation patterns in sterile inflammation and infection.Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.The moderating role of dark soy sauce to acrylamide-induced oxidative stress and neurophysiological perturbations in rats.Protective role of dark soy sauce against acrylamide-induced neurotoxicity in rats by antioxidative activity.Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat.Is therapeutic hypothermia immunosuppressive?c-Jun is essential for the induction of Il-1β gene expression in in vitro activated Bergmann glial cells.Upregulation of insulin-like growth factor and interleukin 1β occurs in neurons but not in glial cells in the cochlear nucleus following cochlear ablation.Effect of hyperbaric oxygen combined with nimodipine on treatment of diffuse brain injury.
P2860
Q24814542-496F27E1-2C6A-428B-9B07-99B6D0EDF49DQ27006513-DC9C985B-0C22-4457-8271-84056CFF4EA3Q28730944-E72D5AFC-780C-4119-9323-FEFF5E86D032Q33519563-E57217EA-2CE9-4BC4-BD9C-EFCA79905111Q33568656-AC4F908F-F553-4313-8946-1B288952B1DEQ33772460-46B797F3-A103-4FE6-BDB7-A9DA5FFA6075Q34039325-6B04F013-6E17-44B0-8845-C09ADE7B1B3EQ34344783-1C94C41C-2D08-4937-ACDC-F294A803C199Q34720755-750590ED-9F62-4692-90F0-22EB611EA247Q34825010-E86C5256-A6E0-44F6-B8E9-382417D3044BQ35103371-C2600DAD-ED09-448C-90F6-5DF61A110D66Q36513532-E2A5A2B0-86A9-4EA0-873A-F5FA2981BC5FQ37040824-0A2C2BE4-E838-4E4A-ADDE-903AED824677Q37059280-2EF237EE-C2B9-468E-ADD4-3CA45E6AE360Q37089253-8117BB59-CD2E-4747-8C72-CB6CD381795CQ37095615-3661174B-F4BE-4A0F-AF4A-91C694C9CE23Q37212082-076A01C3-4E08-4EB0-ACA8-FBB800336403Q37626890-4D6AA2D0-7F92-4DCE-9FB7-0A1AB9BD5E20Q37636646-ADEA4761-C354-4A43-B790-C859BC9B1E9DQ37714376-97A84B84-63E9-4361-B7F3-C6824EB5BD2BQ38196884-49CA01C1-BC3E-433F-8F45-CE77AE906A39Q38602233-5EFC5DC3-DDBF-4215-A9D4-0AD29D0F8BBEQ40185660-C4AA50C3-B207-476F-86B7-8B24952AB6C8Q41616792-2347DFF6-B79A-4D14-9375-AD37A19E49D7Q43271975-D42BF103-8DD6-4087-87C9-40ECE3A9FCF6Q43271999-030F5479-B6B3-42F3-A354-7F15FE42C36BQ44939798-177EBB9B-7B84-43DE-A889-B3FB232E5454Q46180651-1985C126-1F4D-4F54-8113-D4C4FB7C5D46Q48878884-CF601A51-7240-4B96-AB32-4FE7BA8DE73EQ50357179-086C1E55-FDB7-4C97-9605-B1B5AF29354CQ55311915-85FA0BCA-705D-4034-A29B-2C0679E126AE
P2860
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@ast
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@en
type
label
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@ast
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@en
prefLabel
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@ast
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.
@en
P1476
Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration
@en
P2093
P2860
P356
10.1111/J.1749-6632.2003.TB03136.X
P407
P577
2003-05-01T00:00:00Z